Amphastar Pharmaceuticals, Inc. (AMPH) Profit Margins
Over the twelve months to 2026-06-30, Amphastar Pharmaceuticals, Inc. (AMPH) had gross margin 47.7%, operating margin 15.7%, net margin 10.8%, free cash flow margin 20.9%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AMPHAmphastar Pharmaceuticals, Inc.Follow AMPH — free
—
Price chart with a free account
- Market cap
- 1.1B
- P/E TTM
- 14.9
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 24.4% | 30.8% | 40.8% | 37.7% | 36.3% | 40.9% | 41.0% | 45.6% | 49.9% | 54.5% | 51.1% | 49.5% | 47.7% | |
| Operating margin | -8.5% | -2.7% | 6.0% | -0.5% | -2.9% | -0.0% | 3.1% | 16.0% | 21.5% | 30.6% | 28.1% | 19.5% | 15.7% | |
| Net margin | -5.1% | -1.1% | 3.8% | 1.5% | -1.9% | 15.2% | 0.4% | 14.2% | 18.3% | 21.3% | 21.8% | 13.6% | 10.8% | |
| FCF margin | 0.3% | -2.1% | 6.7% | 1.7% | -2.9% | 0.1% | 6.7% | 16.1% | 13.1% | 22.6% | 23.5% | 16.8% | 20.9% |
USD billions · SEC XBRL
Amphastar Pharmaceuticals, Inc. — questions
- What is Amphastar Pharmaceuticals, Inc.'s gross margin?
- 47.7% over the twelve months to 2026-06-30.
- What is Amphastar Pharmaceuticals, Inc.'s operating margin?
- 15.7% over the twelve months to 2026-06-30.
- What is Amphastar Pharmaceuticals, Inc.'s net profit margin?
- 10.8% over the twelve months to 2026-06-30.
Every figure on this page comes from Amphastar Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.